Cargando…
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19
While establishing worldwide collective immunity with anti SARS-CoV-2 vaccines, COVID-19 remains a major health issue with dramatic ensuing economic consequences. In the transition, repurposing existing drugs remains the fastest cost-effective approach to alleviate the burden on health services, mos...
Autores principales: | Desvaux, Emiko, Hamon, Antoine, Hubert, Sandra, Boudjeniba, Cheïma, Chassagnol, Bastien, Swindle, Jack, Aussy, Audrey, Laigle, Laurence, Laplume, Jessica, Soret, Perrine, Jean-François, Pierre, Dupin-Roger, Isabelle, Guedj, Mickaël, Moingeon, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297899/ https://www.ncbi.nlm.nih.gov/pubmed/34293006 http://dx.doi.org/10.1371/journal.pone.0254374 |
Ejemplares similares
-
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
por: Soret, Perrine, et al.
Publicado: (2021) -
Sounding the alarmins—The role of alarmin cytokines in asthma
por: Gauvreau, Gail M., et al.
Publicado: (2022) -
Schizophrenia and Alarmins
por: Ma, Huan, et al.
Publicado: (2022) -
When Alarmins Are “Therapeutic”
por: Vinchi, Francesca
Publicado: (2020) -
Applications of transcriptomics in support of drug development for osteoarthritis
por: Kaplon, Hélène, et al.
Publicado: (2021)